Sam M. Mbulaiteye is a Ugandan physician-scientist and epidemiologist who researches Burkitt lymphoma. He is a senior investigator at the National Cancer Institute.
Sam Mbulaiteye | |
|---|---|
 | |
| Alma mater | Makerere University University of Cambridge |
| Scientific career | |
| Fields | Cancer epidemiology |
| Institutions | National Cancer Institute |
Life
editMbulaiteye received physician training at Makerere University (1990) with advanced training in epidemiology and biostatistics (M.Phil.) from the University of Cambridge (1994), and specialist training in internal medicine (M.Med.) from Makerere University (1996).[1] His early research focused on measuring the impact of HIV on cancer in patients at the Uganda Cancer Institute from 1994 and 1997 and investigating population trends of HIV in a general population in rural southwest Uganda while at the Uganda Virus Research Institute and U.K. Medical Research Council HIV program.[1]
In December 2000, Mbulaiteye joined National Cancer Institute's (NCI) infections and immunoepidemiology branch (IIB) to focus his work on KS and Burkitt lymphoma (BL) as a research fellow, and was awarded NIH scientific tenure and appointed senior investigator in 2013.[1] He conducts research to understand the etiology of BL.[1] Mbulaiteye is the co-editor-in-chief of Infectious Agents and Cancer.[1][2]
References
edit- ^ a b c d e "Sam Mbulaiteye, MBChB, M.Phil., M.Med., biographical sketch and research interests - NCI". dceg.cancer.gov. 1980-01-01. Retrieved 2022-10-25.
This article incorporates text from this source, which is in the public domain.
- ^ "Sam M. Mbulaiteye, M.D. | Principal Investigators | NIH Intramural Research Program". irp.nih.gov. Retrieved 2022-10-25.
This article incorporates public domain material from websites or documents of the National Institutes of Health.
  | This Ugandan biographical article related to medicine is a stub. You can help Wikipedia by expanding it. |